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DOI 10.1016/j.immuni.2011.03.028SUMMARY allergen-loaded cells by cytotoxic activity (Bour et al., 1995;A prominent feature of sensitizing environmental
compounds that cause allergic contact dermatitis is
the rapid induction of an innate inflammatory
response that seems to provide danger signals for
efficient T cell priming. We generated mouse models
of mast cell deficiency, mast cell-specific gene inac-
tivation, and mast cell reporter mice for intravital
imaging and showed that these adjuvant effects of
contact allergens are mediated by mast cells and
histamine. Mast cell deficiency resulted in impaired
emigration of skin DCs to the lymph node and
contact hypersensitivity was dramatically reduced
in the absence of mast cells. In addition, mast cell-
specific inactivation of the Il10 gene did not reveal
any role for mast cell-derived IL-10 in the regulation
of contact allergy. Collectively, we demonstrate
that mast cells are essential promoters of contact
hypersensitivity, thereby highlighting their potential
to promote immune responses to antigens entering
via the skin.
INTRODUCTION
Contact allergy is a common skin disease of high socioeconomic
relevance caused by delayed type hypersensitivity (DTH)
responses to environmental antigens (reviewed for example in
Grabbe and Schwarz, 1998; Belsito, 1999). An important group
of contact allergens are small organic compounds that rapidly
penetrate into the skin and bind to proteins in the dermis,
a process called ‘‘haptenization’’ that renders self-proteins anti-
genic. Skin resident DCs take up themodified proteins and prime
allergen-specific T cells in the skin-draining lymph nodes (LNs),
a process called ‘‘sensitization.’’ Upon a second antigen
encounter, these T cells rapidly accumulate in allergen-exposed
skin where they release proinflammatory cytokines and destroyWang et al., 2000). Awidely used animal model of human contact
allergy, contact hypersensitivity (CHS), is the DTH response to
small organic haptens with potent sensitizing capacity in the
mouse (Grabbe and Schwarz, 1998). Mice are usually sensitized
on the shaved trunk, and sensitization is followed by challenge
(also referred to as ‘‘elicitation’’) on the ear several days later
and monitoring of ear skin inflammation thereafter (Grabbe and
Schwarz, 1998). Evidence that the sensitizing potential of
a compound depends on its capacity to provide danger signals
has accumulated over the past years (Grabbe et al., 1996,
Vocanson et al., 2009, Martin and Jakob, 2008). Haptens used
to induce CHS rapidly evoke a local inflammatory response
within the first hours after administration (Enk and Katz, 1992).
This early innate immune response provides adjuvant effects
that promote the induction of the subsequent allergen-specific
T cell response (Bonneville et al., 2007). The skin-based cell
types that initially sense the haptens and mediate their
adjuvant effects remain to be identified. Because mast cells
(MCs) are capable of rapidly releasing proinflammatory media-
tors, they seem to be particularly promising candidates for this
task.
MCs are best known as effector cells of IgE-mediated allergic
responses, but over the past years important functions of MCs in
innate and adaptive immunity, pathogen defense, and autoim-
mune diseases have been reported (reviewed in Abraham and
St John, 2010; Dawicki and Marshall, 2007; Marshall, 2004; Galli
et al., 2005;McNeil et al., 2007). The role ofMCs in CHS has been
considered controversial with several studies reporting MC
dependency of CHS (Biedermann et al., 2000; van Loveren
et al., 1983), whereas others described undiminished CHS under
conditions of MC deficiency (Galli and Hammel, 1984; Mekori
and Galli, 1985). Recently, Grimbaldeston et, al. (2007) even re-
ported enhanced CHS in MC-deficient mice and concluded that
MCs suppress contact dermatitis. All these studies, because of
the lack of better models, relied on mice carrying mutations of
the MC growth factor SCF or its receptor Kit to obtain various
degrees of MC deficiency. SCF or Kit mutant mice have been
widely used for the investigation of MC functions in vivo over
the past 30 years (Galli et al., 2008; Grimbaldeston et al.,Immunity 34, 973–984, June 24, 2011 ª2011 Elsevier Inc. 973
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models has to take into account that the mutant mice feature
complex alterations of their immune system, which go beyond
the lack of MCs (Nigrovic et al., 2008). Therefore, alternative
models of MC deficiency are needed for exploring roles of
MCs in immune responses in vivo. Promoting functions of MCs
in CHS were implied by experiments in IgE-deficient mice and
in animals with defective Fc3R signaling (Bryce et al., 2004,
Kobayashi et al., 2010).
Based on our MC-specific Cre transgenic line (Scholten et al.,
2008), we have now developed mouse models of inducible or
constitutive deficiency for connective tissue type MCs, in which
the immune system is not altered except for effects of MC defi-
ciency. Analysis of CHS in these animals reveals that selective
MC deficiency results in an almost complete abrogation of the
allergic T cell response. We also show that the early innate
immune response induced by the adjuvant effects of the hapten
is dependent on MCs. Collectively, we demonstrate that MCs
promote CHS and question current views on the immunosup-
pressive potential of these cells (Galli et al., 2008). Our findings
highlight the potential of MCs to stimulate adaptive immune
responses to antigens entering via the skin.
RESULTS
Mouse Models of Inducible or Constitutive MC
Deficiency
In order to investigateMC functions in vivo, we generatedmouse
models of inducible or constitutive MC deficiency, which were
based on our MC-specific Cre transgenic line, Mcpt5-Cre
(Scholten et al., 2008). As shown by a cross to the Cre excision
reporter line R26Y (Srinivas et al., 2001),Mcpt5-Cre mice delete
loxP-flanked genomic DNA with high efficiency in MCs, whereas
no deletion occurs in other cell types in the peritoneal cavity or
spleen (Scholten et al., 2008). In ear skin cell suspensions,
97.5% of MCs expressed EYFP (Figure S1A available online)
and, conversely, 97.3% of EYFP+ cells were MCs, ruling out
Cre activity in a substantial number of non-MCs of the skin.
Expression of the reporter did not occur in blood leukocytes
except for a small fraction of NK cells (Figure S1B).
Mcpt5-Cremice were bred to the iDTR line (Buch et al., 2005),
which expresses a simian diphtheria toxin (DT) receptor selec-
tively in those cells, which delete a loxP-flanked stop element.
Because WT mouse cells are resistant to DT, only MCs were ex-
pected to be sensitive to DT-induced cell death in Mcpt5-Cre+
iDTR+ offspring. Indeed, a single i.p. injection of DT resulted in
an almost complete loss (98.7%) of peritoneal MCs but not
skin MCs 24 hr after DT injection (not shown). Four successive
i.p. injections of DT efficiently depleted peritoneal (Figure 1A)
but also abdominal skinMCs (Figure 1B). However, the depletion
of MCs in ear skin, which contains two times more MCs than
abdominal skin in C57BL/6 mice, was less efficient (Figure 1B).
Because our intention was to analyze local immune responses
of ear skin, we tested whether MC depletion could be improved
by local administration of DT. Two successive s.c. injections
of DT at the base of the ear pinna resulted in a reduction of
ear MC numbers to 11.2% (Figure 1B). Combined systemic
(43 i.p.) and local (23 s.c.) treatment depleted 97.5% of MCs
in the ear and was routinely used for CHS experiments974 Immunity 34, 973–984, June 24, 2011 ª2011 Elsevier Inc.(Figure 1B). One week after the last i.p. injection, no significant
alterations in the numbers of other cell types were detected (Fig-
ure 1C and Figure S2). No significant recovery of MC populations
was observed 3 weeks after depletion under steady state condi-
tions or within 1 week under inflammatory conditions (Figure S3).
Analysis of small intestine (not shown) and stomach (Figure S4)
of DT-injectedMcpt5-Cre+iDTR+mice demonstrated that (sube-
pithelial) connective tissue type MCs but not (intraepithelial)
mucosal MCs were efficiently depleted, most likely reflecting
a lack ofMcpt5-Cre transgene expression inMCs of themucosal
type.
For generation of a model of constitutive MC deficiency,
Mcpt5-Cre mice were crossed to the R-DTA line (Voehringer
et al., 2008). In thesemice, cells that have deleted a loxP-flanked
stop cassette express diphtheria toxin A (DTA) and thereby kill
themselves. As expected, Mcpt5-Cre+ R-DTA+ mice showed
a significant reduction of MC numbers in peritoneum and skin
(Figure 1D).
In summary, Mcpt5-Cre iDTR and Mcpt5-Cre R-DTA mice
represent useful models of inducible or constitutive deficiency
of connective tissue type MCs that, in contrast to the various
Kitmutant lines used to date, are characterized by an otherwise
normal immune system.
Reduced CHS Responses in MC-Deficient Mice
In order to investigate the role of MCs in the CHS response to
haptens, we epicutaneously sensitized MC-depleted Mcpt5-
Cre+iDTR+ mice as well as DT-injected Cre-iDTR+ littermate
and WT control mice at the back and challenged them 6 days
later on the ear. The subsequent ear swelling was quantified as
a measure of the inflammatory response. The CHS response to
DNFB was significantly reduced in MC-depleted Mcpt5-Cre+
iDTR+ mice in comparison to the controls (Figure 2A). In consti-
tutively MC-deficient Mcpt5-Cre+R-DTA+ mice, the ear thick-
ness at 24 hr after DNFB challenge was found reduced to 50%
compared to controls (Figure 2B). In order to exclude that our
finding of reduced CHS to DNFB reflected a specific property
of this allergen, we investigated the response to an additional
standard hapten, FITC. As shown in Figure 2C, the CHS
response to FITC was also strongly reduced in MC-depleted
Mcpt5-Cre+iDTR+ mice versus DT-injected controls.
The diminished response to DNFB in MC-depleted mice was
reflected by a reduced infiltration of CD45+ leukocytes into the
ear 24 hr after DNFB challenge (Figure 2D). In particular, the
numbers of T cells were significantly lower in MC-deficient
mice versus controls. The relative number of neutrophils was
not different between the groups indicating approximately half
the absolute number of neutrophils in the MC-deficient group.
By injection of DT only at the base of the ear pinna, ears can be
locally depleted of MCs (Figure 1B) leaving MCs at other loca-
tions unaffected. This offers the possibility of sensitization on
the MC-proficient back followed by challenge on the MC-
depleted ear. As shown in Figure 2E, the response to DNFB
was significantly reduced under these conditions. However,
the reduction was not as pronounced as in completely MC-defi-
cient mice, indicating that MCs contribute to both, the sensitiza-
tion and the elicitation phase of CHS.
Collectively, our results show that MCs are essential for the
induction of CHS to DNFB and FITC.
Figure 1. Efficient DT-Mediated MC Deple-
tion in Mcpt5-Cre iDTR Mice and MC Defi-
ciency in Mcpt5-Cre R-DTA Mice
(A) Mean peritoneal MC numbers ± SD in Mcpt5-
Cre+ iDTR+ mice (n = 4) and Cre- controls (n = 4)
after four i.p. injections of DT.
(B) Mean MC numbers ± SD ofMcpt5-Cre+ iDTR+
mice andCre- controls in abdominal skin after four
DT injections i.p. (left) and ear skin after combined
systemic and local DT-treatment as indicated.
MCs were identified by Giemsa-staining on tissue
sections; n = 5 for all groups.
(C) Peritoneal and blood leukocyte subsets
determined by FACS in Mcpt5-Cre+ iDTR+ mice
(n = 5) and Cre- controls (n = 4) after four i.p. plus
two s.c. injections of DT; mean ± SD (D) Mean MC
numbers ± SD of 8-week-oldMcpt5-Cre+ R-DTA+
(n = 7) and Cre control mice (n = 12) in peritoneal
cavity (FACS) and skin (histology).
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Grimbaldeston et al. (2007) reported that MCs suppress contact
allergy by provision of IL-10. We generated mice with a selective
inactivation of the Il10 gene in MCs by crossing the Mcpt5-Cre
line to Il10fl/fl mice (Roers et al., 2004). Efficiency of Il10 gene
inactivation in Mcpt5-Cre+Il10fl/fl MCs was demonstrated by
single-target amplification of the Il10 locus of single FACS-
sorted peritoneal or skin MCs or non-MCs. The fragment
amplified from MCs always represented the deleted but never
the loxP-flanked situation, whereas the opposite result was ob-
tained from non-MCs or from all Cre- control cells. Therefore,Immunity 34, 973–9the deletion was efficient in MCs and
was not detected outside the MC lineage
(Table S1).
CHS to DNFB was induced in Mcpt5-
Cre+Il10fl/fl mice by the exact same pro-
tocol as in Grimbaldeston et al. (2007)
but was found unchanged in comparison
to controls, whereas Il10/ mice (Ku¨hn
et al., 1993) displayed enhanced CHS as
expected (Berg et al., 1995) (Figure 2F).
The finding that CHS is not enhanced in
MC-specific Il10 deficient mice is in
accordance with the observation that
induced MC deficiency results in a major
reduction, but not an increase, of theCHS
response. Thus, the effect MCs exert on
CHS is stimulatory and not suppressive.
Contact Allergens Induce
a MC-Dependent Immediate
Response of the Skin Vasculature
In order to address the mechanisms of
the stimulatory effect MCs exert on
CHS, we directly visualized MCs and
blood vessels in untreated and DNFB-
treated ear skin by intravital 2-photon
microscopy. Analysis of untreated ears
of Mcpt5-Cre+R26Y+ MC-reporter micerevealed that a large fraction of MCs was located in close prox-
imity to blood vessels and displayed an elongated or spindle-like
morphology partially oriented in parallel to the vessel axis
(Figures 3A and 3B and Movie S1). When mice were challenged
by DNFB via the ear skin during the ongoing intravital observa-
tion, we noticed a dramatic and rapid increase in blood vessel
diameters withinminutes after DNFB (Figures 3C and 3D;Movies
S2A and S2B), which lasted several hours. In addition, we found
that the intravasal dye leaked out of the vessel lumen in DNFB-
but not vehicle-treated ears, indicating increased vessel perme-
ability (Figures 3E and 3F, Movie S3, andMovie S4). This leakage84, June 24, 2011 ª2011 Elsevier Inc. 975
Figure 2. The CHS Response Is Dependent on MCs and Is Not Counterregulated by MC-Derived IL-10
(A) CHS to DNFB in MC-depletedMcpt5-Cre+iDTR+ mice (n = 8), DT-injected Cre controls (n = 8), untreated WT mice (n = 5), and vehicle (veh) controls (n = 3);
mean ± SD; *p < 0.005.
(B) CHS to DNFB in Mcpt5-Cre+ R-DTA+ mice (n = 5), Cre controls (n = 5), and vehicle controls (n = 3). Mean ear swelling ± SD 24 hr after challenge is shown;
*p < 0.005.
(C) CHS to FITC in MC-depletedMcpt5-Cre+iDTR+mice (n = 4),Cre controls (n = 4), and vehicle controls (n = 3). Mean ear swelling ± SD 24 hr after challenge is
shown; *p < 0.005.
(D) FACS analysis of ear skin cell suspensions generated 24 hr after DNFB challenge fromMC-depletedMcpt5-Cre+iDTR+ (n = 8), DT-injectedCre control (n = 8),
and vehicle-treated (n = 5) Cre mice; ***p < 0.005, *p < 0.05.
(E) CHS to DNFB in Mcpt5-Cre+iDTR+ mice and Cre controls injected with DT at the base of the ear pinna but not systemically. Mice were sensitized on the
MC-proficient back and challenged at the MC-depleted ear; mean ± SD, *p < 0.05, n = 4 per group.
(F) CHS to DNFB in WT (n = 3), Il10/ (n = 7), Mcpt5-Cre+Il10fl/fl (n = 5) and Cre-Il10fl/fl littermate controls (n = 14). Protocol for CHS induction exactly as in
Grimbaldeston et al. (2007); mean ± SD, *p < 0.005.
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untreated ear skin revealed that MCs were immobile cells with
little motion on the cell periphery (Movie S2A). Also after DNFB976 Immunity 34, 973–984, June 24, 2011 ª2011 Elsevier Inc.challenge, we did not observe significant MCmigration or lymph
vessel entry within an observation period of 12 hr after
DNFB. However, allergen challenge induced changes of MC
Figure 3. Intravital Two-Photon Microscopy
of Mcpt5-Cre+R26Y+ Mice Reveals that Ear
Skin MCs and Blood Vessels Respond to
DNFB
Arrayof333maximumintensityprojections (A)and
surface-rendered Z stack (B, Movie S1) showing
distribution and morphology of MCs (green), blood
vessels (i.v.-injected redQdots), andcollagenfibers
(gray) of untreated skin. DNFB challenge in sensi-
tized mice induces vasodilatation (C and D; Movie
S2) andQdot leakage (E andF;MovieS3 andMovie
S4), as well as changes in MC morphology (G–L,
Movie S5 and Movie S6); maximum intensity
projections (G and H), surface-rendered Z stacks (I
and J, blow-ups from G and H, respectively), and
array of 33 3 maximum intensity projections (K).
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the branched and spindle-like appearance to adopt more glob-
ular shapes (Figures 3G–3L, Movie S5, and Movie S6). Initially,
only few MCs underwent these changes while most MCs were
affected after 24 hr. This phenomenon did not occur after treat-
ment with vehicle alone (not shown).
Because MCs are known to induce rapid vascular responses
by releasing prestored mediators, we examined whether the
immediate response of the vasculature to contact allergens
was mediated by MCs. Intravital imaging allowed direct
measurement of diameters of individual skin blood vessels
before and after allergen administration. DNFB-treatedImmunity 34, 973–9Cre-iDTR+ control mice reproduced the
dilatation of blood vessels described
above. However, in Mcpt5-Cre+iDTR+
animals the dilatation of larger (R18 mm)
vessels was significantly reduced
compared to the controls, whereas
smaller (<18 mm) vessels showed undi-
minished dilatation (Figure 4A). A quanti-
tative comparison of the DNFB-induced
leakage of the intravascular dye in MC-
depleted versus control mice proved diffi-
cult because of local variation of this
phenomenon. Therefore, we relied on
ear thickness measurements for quantifi-
cation of the tissue edema. In our hands,
DNFB caused an immediate ear swelling
that peaked after 2 hr (Figure S5). In sensi-
tized mice, this first peak was followed by
a second increase in ear thickness peak-
ing at 24 hr (Figure S5). Also urushiol,
TNCB, FITC, and oxazolone induced an
early ear swelling with a maximum
between 1 and 2.5 hr after exposure (Fig-
ure S5) preceding the later T cell-medi-
ated allergic inflammation. Thus, an early
inflammatory response is a common
theme in sensitization to haptens. As
shown in Figure 4B, the immediate ear
swelling response in sensitized and non-
sensitized control mice was almostcompletely abrogated in the MC-depleted animals. The MC-
dependence of this response was confirmed in Mcpt5-Cre+
iDTR+ mice after local MC-depletion in ear tissue only (data not
shown) and also inMC-deficientMcpt5-Cre+R-DTA+ (Figure 4C),
KitW/W-v, andKitW/WEPO-tgmice (see below). Like the immediate
response to DNFB, also the immediate response to FITC was
almost completely abrogated in MC-depletedMcpt5-Cre+iDTR+
mice (Figure 4D). Thus, a prominent effect of haptens is the
immediate induction of a vascular response that is dependent
on MCs and that occurs independent of prior sensitization. The
MCs act as amplifier of the dilatation of larger vessels and
mediate a rapid increase in vessel permeability.84, June 24, 2011 ª2011 Elsevier Inc. 977
Figure 4. The Early Innate Response to
Haptens Is MC Dependent
(A) Increase in blood vessel diameter in ear skin of
sensitized Mcpt5-Cre+iDTR+ mice and DT-
injected Cre- controls as determined by intravital
two-photon microscopy 1 hr after DNFB challenge
compared to prechallenge diameter. Pooled data
from five Cre+ and five Cre- mice; ***p < 0.005.
(B) Ear swelling response to DNFB in sensitized or
nonsensitized MC-depleted Mcpt5-Cre+iDTR+
mice (n = 5), DT-injected Cre controls (n = 5),
and vehicle (veh) controls (n = 3); mean ± SD,
*p < 0.005, #p < 0.05.
(C) Ear swelling response to DNFB in Mcpt5-
Cre+R-DTA+mice (n = 5) and Cre controls (n = 5);
mean ± SD, *p < 0.005, #p < 0.05.
(D) Ear swelling response to FITC in Mcpt5-Cre+
iDTR+mice (n = 4),Cre controls (n = 4) and vehicle
controls (n = 4); mean ± SD, *p < 0.005, #p < 0.05.
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of the Vasculature after DNFB Challenge but Also Affect
the Subsequent CHS Response
Because the DNFB-induced early response of the vasculature
was dependent on MCs, we quantified MC degranulation on
Giemsa-stained paraffin sections of ears taken 30 min or 1 hr
after DNFB or FITC challenge. As shown in Figure S6, allergen
treatment resulted in microscopically evident MC degranulation.
We next examined whether MC degranulation and histamine are
required for the DNFB-induced immediate response of ear skin
blood vessels. Therefore, DNFB-sensitized or unsensitized WT
mice were pretreated with the MC-stabilizing agent cromolyn
or the histamine receptor-1 antagonist pyrilamine 1 hr before
DNFB challenge and the ear swelling response to DNFB was
quantified. Pretreatment of the animals with cromolyn (Figure 5A)
or pyrilamine (Figures 5B and 5D) resulted in a reduced DNFB-
induced immediate ear swelling response. Likewise, the imme-978 Immunity 34, 973–984, June 24, 2011 ª2011 Elsevier Inc.diate response to FITCwas greatly dimin-
ished in pyrilamine pretreated animals
(Figure 5C).
Interestingly, cromolyn and pyrilamine
not only blocked the immediate response
but also significantly reduced the subse-
quent increase in ear thickness in sensi-
tized mice that reflected the adaptive
CHS response (Figures 5A–5C). This
observation prompted the question
whether histamine action during the first
hours after DNFB challenge was
important for the T cell-mediated CHS
response. To address this question, we
used a modified CHS protocol that relies
on a single DNFB administration (chal-
lenge dose of 20 ml, 0.2% DNFB) on the
ear without prior sensitization (Saint-
Mezard et al., 2003). In naive animals,
DNFB painting of the ear results in sensi-
tization but because of persistence of the
allergen in the tissue, DNFB painting alsoelicits CHS and an ear swelling response beginning about 48 hr
after allergen exposure. This ‘‘primary’’ CHS response is of
similar intensity as compared to the response of sensitized
mice but occurs 40 hr later. This system offered the possibility
to block histamine during the initial allergen contact and investi-
gate the CHS response that ensued without secondary allergen
challenge. To exclude that the histamine blockade was long-
lasting and directly affected the CHS response 72 hr after
DNFB, we demonstrated that pyrilamine effects were no longer
detectable after 48 hr. The histamine-mediated immediate
response to DNFB was fully restored at this time point (not
shown). Pyrilamine injection 1 hr before allergen exposure
blocked the immediate ear swelling (as shown above) but also
resulted in a significant reduction of the CHS response
commencing 48 hr later (Figure 5D).
In summary, the immediate response of the vasculature to
DNFB and FITC is mediated by histamine most likely released
Figure 5. Early Innate Response to Haptens
Is Dependent on Histamine
(A–C) Ear swelling response to DNFB or FITC in
sensitized or nonsensitized WT mice, untreated or
pre-treated with cromolyn (A) or pyrilamine (B and
C);n=5all groups,mean±SD, *p<0.005, #p<0.05.
(data from the same single experiment are shown in
A and B, untreated control groups of sensitized and
non-sensitized WT mice are identical in A and B).
(D) ‘‘Primary’’ CHS response after a single DNFB
administration on the ear (20 ml, 0.2% DNFB in
aceton/oil) in nonsensitizedWTmice untreated (n =
5) or pretreated with pyrilamine (n = 5); mean ± SD,
*p < 0.01, #p < 0.05.
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histamine effects during the first hours after DNFB are of critical
importance for the allergic sensitization.
MCs Promote DC Migration and Hypertrophy of Lymph
Nodes Draining Contact Allergen-Treated Skin
In order to investigate whether MCs impact on the immune
response to DNFB, we sensitizedmice on the back and analyzed
the inguinal LNs 72 hr later. The LNs were macroscopically
enlarged in DNFB-treated mice (data not shown) and contained
two times more cells as compared to untreated mice (Figure 6A).
In contrast, LNs from MC-depleted Mcpt5-Cre+iDTR+ mice dis-
played a significantly less pronounced DNFB-induced increase
in cellularity, that primarily reflected lower numbers of T cells
and DCs as compared to DT-injected Cre control LNs
(Figure 6A).
Sensitization with haptens results in emigration of DCs from
the skin to the draining LNs (Kripke et al., 1990). One mecha-
nism through which MC-mediated effects may promote the
adaptive immune response against haptens could be theImmunity 34, 973–9stimulation of DC migration. Painting of
the skin with the contact allergen FITC
results in an accumulation of FITC+DCs
in skin draining LNs, which reflects DC
migration from the skin into the LNs
(Kripke et al., 1990). In order to deter-
mine MC effects on DC migration during
the sensitization phase, we treated MC-
depleted mice and DT-injected controls
with FITC on the back and analyzed
the inguinal LNs 48 hr later. Figure 6B
shows that the response to FITC re-
sulted in increased LN DC numbers in
the control group, similar to the numbers
observed after DNFB exposure (Fig-
ure 6A). Importantly, total LN cellularity
and total DC numbers were reduced
and the number of FITC+DCs was two
times lower in the MC-depleted group
as compared to controls (Figure 6B).
These results show that MCs have
important stimulatory effects on the
response of the adaptive immune
system to haptens. Stimulation of DCmigration seems to be one mechanism by which MCs promote
contact allergy.
Kit Mutant Mice Display Enhanced CHS but Differ
in their Early Innate Response to DNFB
Grimbaldeston et al. (2007) reported enhanced CHS to DNFB in
the MC-deficient lines KitW/W-v and KitW-sh/W-sh. Also in our
hands, these mice displayed enhanced and prolonged ear
swelling responses to DNFB as compared to Kit+/+ controls
(Figures 7A and 7B). The immediate ear swelling response to
DNFB, which we had found in control but not MC-depleted
mice in the Mcpt5-Cre iDTR system, was absent in KitW/W-v
and in KitW/W mice rescued from early lethality by an EPO trans-
gene (KitW/WEpo-tg, Waskow et al., 2004; Figures 7C and 7D),
supporting the MC dependence of this phenomenon. Interest-
ingly, we observed an immediate ear swelling response to
DNFB in KitW-sh/W-sh mice (Figure 7E) that was similar to the
response of control mice. This response was not due to residual
MCs given that we found the MC numbers in ear skin reduced to
less than 1% of normal numbers in the 12-week-old KitW-sh/W-sh84, June 24, 2011 ª2011 Elsevier Inc. 979
Figure 6. MCs Promote Hapten-Induced LN
Hypertrophy and DC Migration
FACS analysis of skin draining LNs.
(A) Numbers of the indicated cellular subsets in
inguinal LNs 72 hr after DNFB sensitization at the
back of Mcpt5-Cre+iDTR+ mice (n = 8) and Cre-
controls (n = 8) compared to vehicle-treated WT
mice (n = 8); ***p < 0.005, *p < 0.05.
(B) Mcpt5-Cre+iDTR+ mice (n = 8) and Cre-
controls (n = 12) were sensitized with FITC on the
back. Forty-eight hours later, the number of CD45+
cells, CD11c+MHCII+ DCs and FITC+CD11c+
MHCII+ DCs were determined in inguinal LNs;
***p < 0.005.
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absence of the immediate response in all other MC-deficient or
MC-depleted mice analyzed in this study. We thus examined
whether the immediate response of KitW-sh/W-sh animals was
mediated by histamine. As shown in Figure 7F, the early
DNFB response was efficiently suppressed by pretreatment of
KitW-sh/W-sh mice with pyrilamine but only mildly reduced by
injection of the MC stabilizer cromolyn, suggesting that some
other histamine producing cell type could be responsible for
the early DNFB response in these mice. Neutrophils were shown
to contribute to inflammation in a histamine-dependent fashion
(Xu et al., 2006). In order to test, whether the immediate response
of KitW-sh/W-sh mice was mediated by neutrophils, we depleted
Gr-1-positive cells prior to DNFB painting. This treatment re-
sulted in a significant reduction of the immediate ear swelling
response of KitW-sh/W-sh mice, whereas injection of an isotype
control antibody had no effect (Figure 7G).
Collectively, we confirmed that the Kit mutant lines KitW/W-v
and KitW-sh/W-sh show enhanced CHS responses to DNFB. This
enhanced immune response, however, is not caused by the
MC deficiency of these mice because selective depletion of
MCs in our Mcpt5-Cre+iDTR+ mice or MC deficiency in the
Mcpt5-Cre+R-DTA+ animals resulted in a profound reduction of
CHS. In contrast to CHS in WT mice, the enhanced CHS in the
KitW/W-v line was independent of an early innate response.
KitW-sh/W-sh mice mount an abnormal neutrophil- and hista-
mine-dependent early innate response.
DISCUSSION
We have analyzed the role MCs play in contact allergy by using
mouse models of MC deficiency and MC-specific gene inactiva-
tion either lacking the population of connective tissue type MCs
(CTMCs) in all tissues or lacking specific gene products selec-
tively in CTMCs, respectively. Our results clearly demonstrate
that MCs are critical for the CHS response to haptens. CHS
was reduced in mice selectively depleted of MCs by DT-injection
(Mcpt5-Cre iDTR) and in mice that were constitutively980 Immunity 34, 973–984, June 24, 2011 ª2011 Elsevier Inc.MC-deficient without the requirement
for toxin injections (Mcpt5-Cre R-DTA).
The question of whether MCs
contribute to contact allergy was ad-
dressed by numerous studies over thepast decades, which yielded heterogeneous results. Several
reports described undiminished CHS, whereas others found
reduced or enhanced CHS in different MC-deficient mouse lines.
These discrepant findings may be partially explained by the use
of different contact allergens, the use of different protocols for
CHS elicitation, quantification of the inflammatory response at
different time points, and the mouse models employed.
Mice with compromised SCF-Kit axis have been widely used
as models of MC deficiency (Galli et al., 2008). Most of the pub-
lished literature on in vivo MC functions was based on these
models. However, Kit is expressed also outside the MC lineage,
in particular in hematopoietic stem cells and precursor cells of
most lineages. Therefore, Kit deficiency results in complex alter-
ations of many hematopoietic compartments. Both, KitW/W-v
and KitW-sh/W-sh mice are almost completely MC deficient by
the age of 12 weeks. However, the two lines differ dramatically
from each other in various immune parameters: KitW/W-v
developmacrocytic anemia and neutropenia, display a decrease
of intestinal gd but an increase in intestinal ab T cells, and have
a high rate of spontaneous dermatitis. KitW-sh/W-sh mice are
characterized by an enlarged spleen with abnormal architecture
and increased splenic myeloid cell and megacaryocyte counts,
as well as peripheral blood neutrophilia and thrombocytosis.
Notably, the lines behaved differently in some disease models
(Zhou et al., 2007; Piliponsky et al., 2010). In line with this notion,
we show here that the two MC-deficient Kit mutant lines dis-
played fundamentally different innate responsiveness to contact
allergens. These differences between the two lines illustrate the
alteration of their immune system beyond MC deficiency. In
order to demonstrate that a phenotype observed in Kit mutants
is due to their MC-deficiency, we routinely reconstituted these
mice with bone marrow-derived MCs differentiated in vitro
(BMMC). Rescue of an observed phenotype by this MC recon-
stitution was interpreted as proof that the phenotype was due to
the loss of MC functions. Using this ‘‘MC knock-in’’ model,
Grimbaldeston et al. (2007) showed that the exaggerated CHS
response of KitW/W-v and KitW-sh/W-sh mice was reduced to
normal levels by reconstitution with BMMC from WT but not
Figure 7. Kit Mutant Mice Display Enhanced CHS but Differ in their Early Innate Response to DNFB
(A andB) Ear swelling response to DNFB in sensitizedWBB6F1KitW/Wvmice (n = 8) andWBB6F1Kit+/+ controls (n = 5) or C57BL/6KitW-sh/W-sh (n = 8) andC57BL/6
WT mice (n = 8); mean ± SD, *p < 0.005, #p < 0.05.
(C–E) Ear swelling response to DNFB in nonsensitized WBB6F1 KitW/Wv (n = 8) and WBB6F1 Kit+/+ controls (n = 5), KitW/WEpo-tg (n = 3), KitW/+Epo-tg (n = 3), and
WT controls (n = 4) or C57BL/6 KitW-sh/W-sh (n = 8) and C57BL/6 WT mice (n = 8), *p < 0.005, #p < 0.05.
(F) Ear swelling response to DNFB in sensitized KitW-sh/W-sh mice untreated or pretreated with cromolyn or pyrilamine, n = 5 per group, mean ± SD; *p < 0.005,
#p < 0.05.
(G) Ear swelling response to DNFB in sensitized KitW-sh/W-sh mice untreated or pretreated with an anti-Gr-1 mAb or isotype control, mean ± SD, n = 4 per group,
*p < 0.005, #p < 0.05 (left). The efficiency of neutrophil depletion was determined by FACS analysis of blood leukocytes. Error bars show the mean ± SD of
neutrophil numbers determined as Gr-1hiCD11b+ cells, n = 4 (middle and right).
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provision of IL-10.
We confirmed the enhanced CHS response in the two Kit
mutant lines. However, CHS was significantly reduced in our
Kit-independent mouse models of selective MC deficiency,
which do not display alterations of the immune system except
for the effects of the absence of MCs. We conclude that the
exaggerated CHS in Kit mutant animals is not caused by the
absence of MCs but is related to the Kit deficiency. We also
demonstrate that mice with an efficient Cre-loxP-mediated inac-
tivation of the Il10 gene in MCs (Mcpt5-Cre Il10fl/fl) do not show
enhanced CHS in response to DNFB. Thus, MCs are important
promoters but not suppressors of the CHS response. These
results show, that even if a phenotype observed in a Kit mutant
line can be ‘‘repaired’’ by MC ‘‘knock-in,’’ this does not neces-
sarily proof that the phenotype was caused by the lack of
MCs. Collectively, our data show that Kit mutant mice candisplay alterations of their immune responsiveness that are not
related to their MC deficiency. Therefore, in vivo MC functions
that have been described on the basis of findings in Kit mutant
mouse lines, with or without ‘‘MC knock-in,’’ should be re-eval-
uatedwith usingmousemodels that are independent of compro-
mised Kit signaling.
In accordance with our results, two reports in mutants with
normal Kit signaling suggested an important promoting function
of MCs in CHS. Lack of IgE in IgE/ mice resulted in reduced
CHS responses, which could be restored by exogenous IgE of
irrelevant specificity (Bryce et al., 2004). Similarly, CHS was
reduced in mice with defective Fc3RI signaling (Kobayashi
et al., 2010). These key studies suggest that either tonic
antigen-nonspecific signals from the IgE-loaded Fc3RI may be
required for full responsiveness of MCs to contact allergens or,
alternatively, that the haptens directly activate MCs via the IgE-
Fc3RI axis.Immunity 34, 973–984, June 24, 2011 ª2011 Elsevier Inc. 981
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ization that contact allergens rapidly induce an inflammatory
response of the local innate immune system (Watanabe et al.,
2007; Martin et al., 2008). The intensity of this early response
was demonstrated to correlate with the severity of the subse-
quent T cell-mediated CHS response (Bonneville et al., 2007).
This led to the interpretation that contact allergens have adjuvant
properties that ensure the provision of danger signals for induc-
tion of the hapten-specific T cell response. The molecular basis
of adjuvant effects of a contact allergen were directly demon-
strated in a recent study describing that Ni2+ ions ligate and acti-
vate human TLR4 and that this TLR-mediated activation of innate
immunity is a prerequisite for the allergic sensitization to nickel
(Schmidt et al., 2010).
We attempted to clarify the role of MCs in the early innate
response to haptens and made use of our EYFP-MC reporter
mice (Mcpt5-Cre R26Y) to visualize living MCs in their natural
environment by intravital 2-photon microscopy. In contrast to
other intravital 2-photon imaging approaches, e.g., in LNs, the
imaging of MCs in ear skin was practically noninvasive. Imaging
of MCs in untreated mice demonstrated high numbers of strik-
ingly elongated or spindle-shaped MCs partly in intimate associ-
ation with blood vessels. In time-lapse studies we did not
observe substantial migratory behavior of MCs within the first
12 hr after DNFB. However, we found that MCs responded to
DNFB by changes in morphology. Starting few hours after
allergen treatment, increasing numbers of MC contracted to
adopt more globular shapes. At 24 hr after DNFB, hardly any
MC remained spindle shaped.
Although the biological functions that are reflected by these
morphological changes remain unclear, we show that MCs are
essential for the early innate response to haptens by using our
new MC-deficient mouse lines. Intravital microscopy demon-
strated that the DNFB induced dilation of larger skin blood
vessels was significantly reduced in MC-depleted mice. This
MC-dependent vascular response correlated with the observa-
tion that the early ear swelling response to haptens that occurs
in WT mice and peaks after 1–2 hr was virtually absent in MC-
depleted mice. We also show that this MC-mediated early innate
response is dependent on histamine. This finding was unex-
pected given that an earlier study described enhanced CHS in
micedeficient for histidinedecarboxylase,whichcannot produce
histamine (Garaczi et al., 2004). Histamine effects on the immune
system are highly complex and have e.g., major impact on T cell
differentiation. Therefore, the possibility that the responsiveness
of the adaptive immunesystem is altered in animals that are hista-
mine-deficient throughout ontogeny should be considered.
We show that MCs are essential in the initial activation of an
innate response by adjuvant effects of the haptens. This early
inflammatory response may promote the T cell response to the
hapten by several mechanisms including the induction of DC
migration from the hapten-treated skin into the draining LNs.
We demonstrated that hapten-induced DC migration was
impaired in MC-depleted mice confirming a previous report
(Suto et al., 2006). Our findings are in accordance with a recent
study demonstrating that MC-activating compounds have
potent adjuvant effects in vivo (McLachlan et al., 2008).
Contact allergens differ in their sensitizing potential. Some
contact allergens sensitize all or most exposed individuals,982 Immunity 34, 973–984, June 24, 2011 ª2011 Elsevier Inc.whereas sensitization to weaker allergens occurs only in few
individuals and requires multiple exposures. Factors that predis-
pose these few patients to mount an allergic response are
unknown but may be due to enhanced MC responsiveness.
The difference between potent and weak allergens was linked
to their capacity to induce innate local inflammation, and thus,
their adjuvant potential, which may reflect their MC-stimulating
capacity.
Our results demonstrate thatMCs and histamine are critical for
induction of contact allergy. This raises the possibility that
allergic sensitization in the human could be prevented by antihis-
tamine treatment during exposures to contact allergens.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 KitW-sh/W-sh mice, Il10/ and Mcpt5-Cre mice crossed to the iDTR,
R-DTA, R26Y, or Il10fl/fl lines, as well as KitW/W-v and WT C57BL/6 mice,
were housed at the Experimental Centre at the University of Technology Dres-
den, Medical Faculty Carl-Gustav Carus, under specific pathogen-free condi-
tions. In all experiments, mice were used at the age of 8–16 weeks. Littermates
were used as controls. KitW-sh/W-sh mice were used at the age of 12 weeks to
ensure MC deficiency; WT C57BL/6 mice were used as controls. All proce-
dures were in accordance with institutional guidelines on animal welfare and
were approved by the Landesdirektion Dresden.
Single-Cell Sorting and Single-Target Amplification of the Il10 Locus
Single MCs (Fc3RI+CD117+), macrophages (F4/80+), and B cells (CD19+) from
peritoneal lavage as well as MCs (CD45+Fc3RI+CD117+) and T cells
(CD45+CD3+) from ear skin cell suspensions were sorted into thin-walled
PCR tubes containing PCR buffer (one cell per tube) with the single-cell deflec-
tion module of an FACS Aria II instrument (BD Biosciences). The Il10 locus of
the sorted cells was amplified in a two-rounded nested PCR (see Supple-
mental Experimental Procedures). PCR products were verified by sequencing.
Intravital 2-Photon Microscopy of MCs and Vessels in Ear Skin
Mice were prepared for intravital microscopy as previously described (Ko¨hler
et al., 2009). In brief, animals were subjected to intubation narcosis with
a mixture of isofluran (1.2%) and oxygen with a mechanical ventilator (Mini-
Vent, Hugo-Sachs Elektronik, March-Hugstetten, Germany). Two-photon
intravital microscopy was performed with a Zeiss LSM-710 microscope with
simultaneous detection via three external non-descanned-detectors (NDDs).
Illumination was performed at 950 nm with a MaiTai TiSa-laser (10%–12%
laser power, at 1400mW maximum power) via a 203 water-dipping lens with
1.0 NA. EYFP-expressing MCs were detected in the 500–550 nm emission
window, blood vessels, and vessel leakage by i.v. injection of 20 ml Qtracker
655 nontargeted Qdots (Invitrogen) in 130 ml PBS (detection 640–760 nm).
Skin tissue structure was visualized by its second harmonic generation
(SHG) signal (<485 nm). Image series were recorded every 60 s for 15–
30 min at a depth of 84–88 mm with 4 mm Z spacing. Single images were re-
corded as Z stacks encompassing the entire epidermis and dermis (up to
a depth of 100–120 mm) and analyzed as extended focus images or surface
rendered z-stacks. Raw data were reconstructed using Volocity (Perkin
Elmer/Improvision).
Induced MC Depletion
Six- to eight-week-old Mcpt5-Cre+iDTR+ and Cre littermates received four
successive i.p. injections of 25 ng DT/g bodyweight in weekly intervals. Mice
were used in experiments 1week after the last i.p. DT injection. For CHS exper-
iments, mice were treated systemically (43 25 ng DT/g bodyweight, i.p.) and
locally by two successive subcutaneous injections of 5 ng/g DT at the base
of the ear pinna 6 days and 2 days before allergen challenge onto the ear.
CHS
Mice were sensitized to various haptens on the shaved back and challenged
on the ear. Vehicle controls were sensitized but challenged with the respective
Immunity
Mast Cells Are Critical for Induction of CHSsolvent only. Ear thickness was measured before and at several time points
after challenge with an engineer’s micrometer (Mitutoyo). Ear swelling was
determined as the percent increase compared to prechallenge ear thickness.
For DNFB, mice were sensitized with 100 ml 0.5% (w/v) in acetone/olive oil (4:1)
and challenged 6 days later with 20 ml 0.2% (10 ml each side of the ear). For
FITC, mice were sensitized with 100 ml 1% (w/v) in acetone/dibutylphthalate
(1:1) and challenged 6 days later with 20 ml 0.5% (10 ml each side of the ear).
For urushiol, mice were sensitized with 30 ml 20mg/ml in 100% acetone and
challenged 5 days later with 20 ml 5 mg/ml (10 ml each side of the ear). For
TNCB, mice were sensitized with 100 ml 7% (w/v) in acetone/olive oil (4:1)
and challenged 6 days later with 20 ml 1% (10 ml each side of the ear). For ox-
azolone, mice were sensitized with 25 ml 100 mg/ml in acetone/olive oil (4:1)
and challenged 5 days later with 20 ml 10 mg/ml (10 ml each side of the ear),
as described in the study of Grimbaldeston et al. (2007). Pyrilamine (10 mg/g
bodyweight) and cromolyn (25 mg/g bodyweight) were injected i.v. 1 hr before
challenge. Anti-Gr1 (10 mg/g bodyweight) or isotype control antibody (10 mg/g
bodyweight) was injected i.p. 24 hr before challenge.
Analysis of LN Hypertrophy and DC Migration
Mice were sensitized with 0.5%DNFB on the shaved back. Seventy-two hours
later, both inguinal LNs were isolated and CD45+ cells, CD4+ and CD8+ T cells,
CD19+ B cells, and CD11c+MHCIIhi DCs were quantified by FACS. For evalu-
ation of the DC migration from skin to draining LNs, mice were sensitized with
FITC or vehicle only. Numbers of CD45+ cells, CD11c+ MHCIIhi DCs, and
FITC+CD11c+MHC-IIhi DCs from inguinal LNs were quantified by FACS 48 hr
later.
Statistical Analysis
Data are shown as means ± SD. Statistical analysis was performed with the
Student’s t test. Significance levels are indicated in each figure.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one table, seven figures, six movies, and
Supplemental Experimental Procedures and can be found with this article on-
line at doi:10.1016/j.immuni.2011.03.028.
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